ROLSIGMA Trademark

Trademark Overview


On Tuesday, August 23, 2022, a trademark application was filed for ROLSIGMA with the United States Patent and Trademark Office. The USPTO has given the ROLSIGMA trademark a serial number of 97560126. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, July 16, 2024. This trademark is owned by Minerva Neurosciences, Inc.. The ROLSIGMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors
rolsigma

General Information


Serial Number97560126
Word MarkROLSIGMA
Filing DateTuesday, August 23, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMinerva Neurosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Party NameMinerva Neurosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Trademark Events


Event DateEvent Description
Friday, August 26, 2022NEW APPLICATION ENTERED
Monday, September 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 15, 2023ASSIGNED TO EXAMINER
Wednesday, April 19, 2023NON-FINAL ACTION WRITTEN
Wednesday, April 19, 2023NON-FINAL ACTION E-MAILED
Wednesday, April 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024SOU EXTENSION 1 FILED
Tuesday, February 13, 2024SOU EXTENSION 1 GRANTED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 11, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, July 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 16, 2024SOU EXTENSION 2 FILED
Tuesday, July 16, 2024SOU EXTENSION 2 GRANTED